Focused Wealth Management, Inc Guardant Health, Inc. Transaction History

Focused Wealth Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$28.82 - $77.35 $288 - $773	-10 Reduced 16.67%	50 $2,000
Q4 2021 Jan 31, 2022	BUY	$88.71 - $120.43 $1,330 - $1,806	15 Added 33.33%	60 $6,000
Q3 2021 Oct 12, 2021	BUY	$98.77 - $132.17 $987 - $1,321	10 Added 28.57%	45 $6,000
Q2 2021 Jul 15, 2021	SELL	$109.77 - $165.68 $548 - $828	-5 Reduced 12.5%	35 $4,000
Q1 2021 May 03, 2021	SELL	$127.04 - $179.1 $1,270 - $1,791	-10 Reduced 20.0%	40 $6,000
Q4 2020 Feb 03, 2021	BUY	$99.96 - $135.93 $4,998 - $6,796	50 New	50 $6,000
Q3 2019 Nov 06, 2019	SELL	$62.59 - $110.3 $92,320 - $162,692	-1,475 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$63.94 - $91.11 $94,311 - $134,387	1,475 New	1,475 $127,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.